User login
Elsevier, a world-leading provider of scientific, technical, and medical information products and services, and the American College of Chest Physicians (CHEST), a world-renowned publisher of evidence-based practice guidelines in chest medicine, have announced that Elsevier will publish the organization’s flagship journal CHEST as of January 1, 2016. This significant and exciting piece of news that will positively affect the future of the journal is a licensing agreement, wherein CHEST retains all ownership of the journal, copyright, trademark, and editorial decision-making. Elsevier’s role will be heavily focused on the business and operational aspects of publishing the journal and will provide significant resources to help us continue to take CHEST to a higher level.
“We are excited to begin this new relationship with Elsevier and we look forward to CHEST’s continued success under this collaboration,” said Paul Markowski, CEO and Executive Vice President of the American College of Chest Physicians. “CHEST will remain a leading publication designed to aid clinicians in providing the best patient care possible.”
Dr. Richard Irwin, Master FCCP, and Editor in Chief of the journal, said, “Our publishing agreement with Elsevier will allow CHEST to remain competitive, will help us to distribute research papers to a larger audience, and will allow us to better attract higher profile clinical research from around the world. We anticipate many enhancements to the journal, which will benefit our authors, members, and readers.
”The relationship with Elsevier will allow CHEST to leverage the global capabilities of Elsevier, its ScienceDirect platform, and its new ClinicalKey service to distribute the journal to an even larger audience than ever and attract higher profile research from around the world.
Elsevier, a world-leading provider of scientific, technical, and medical information products and services, and the American College of Chest Physicians (CHEST), a world-renowned publisher of evidence-based practice guidelines in chest medicine, have announced that Elsevier will publish the organization’s flagship journal CHEST as of January 1, 2016. This significant and exciting piece of news that will positively affect the future of the journal is a licensing agreement, wherein CHEST retains all ownership of the journal, copyright, trademark, and editorial decision-making. Elsevier’s role will be heavily focused on the business and operational aspects of publishing the journal and will provide significant resources to help us continue to take CHEST to a higher level.
“We are excited to begin this new relationship with Elsevier and we look forward to CHEST’s continued success under this collaboration,” said Paul Markowski, CEO and Executive Vice President of the American College of Chest Physicians. “CHEST will remain a leading publication designed to aid clinicians in providing the best patient care possible.”
Dr. Richard Irwin, Master FCCP, and Editor in Chief of the journal, said, “Our publishing agreement with Elsevier will allow CHEST to remain competitive, will help us to distribute research papers to a larger audience, and will allow us to better attract higher profile clinical research from around the world. We anticipate many enhancements to the journal, which will benefit our authors, members, and readers.
”The relationship with Elsevier will allow CHEST to leverage the global capabilities of Elsevier, its ScienceDirect platform, and its new ClinicalKey service to distribute the journal to an even larger audience than ever and attract higher profile research from around the world.
Elsevier, a world-leading provider of scientific, technical, and medical information products and services, and the American College of Chest Physicians (CHEST), a world-renowned publisher of evidence-based practice guidelines in chest medicine, have announced that Elsevier will publish the organization’s flagship journal CHEST as of January 1, 2016. This significant and exciting piece of news that will positively affect the future of the journal is a licensing agreement, wherein CHEST retains all ownership of the journal, copyright, trademark, and editorial decision-making. Elsevier’s role will be heavily focused on the business and operational aspects of publishing the journal and will provide significant resources to help us continue to take CHEST to a higher level.
“We are excited to begin this new relationship with Elsevier and we look forward to CHEST’s continued success under this collaboration,” said Paul Markowski, CEO and Executive Vice President of the American College of Chest Physicians. “CHEST will remain a leading publication designed to aid clinicians in providing the best patient care possible.”
Dr. Richard Irwin, Master FCCP, and Editor in Chief of the journal, said, “Our publishing agreement with Elsevier will allow CHEST to remain competitive, will help us to distribute research papers to a larger audience, and will allow us to better attract higher profile clinical research from around the world. We anticipate many enhancements to the journal, which will benefit our authors, members, and readers.
”The relationship with Elsevier will allow CHEST to leverage the global capabilities of Elsevier, its ScienceDirect platform, and its new ClinicalKey service to distribute the journal to an even larger audience than ever and attract higher profile research from around the world.